FCM
TECH icon

Fortis Capital Management’s Bio-Techne TECH Stock Holding History

Fortis Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-30,400
Closed -$1.88M – 127
2020
Q3 		$1.88M Buy
+30,400
New +$1.98M 1.5% 35

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fortis Capital Management's TECH Position: Q4 2020 in Review

Fortis Capital Management sold out of Bio-Techne (TECH) in Q4 2020, closing a stake of 30,400 shares — an estimated $1.88M sold.

Fortis Capital Management first reported a position in TECH in Q3 2020 and held it in 1 quarter. The position peaked at $1.88M in Q3 2020. 440 funds tracked by Wall St. Rank hold TECH as of Q4 2020.

  • Fortis Capital Management reported no remaining Bio-Techne position as of Q4 2020 after selling out during the quarter.
  • Fortis Capital Management sold 30,400 Bio-Techne shares in Q4 2020, an estimated $1.88M.
  • Fortis Capital Management first reported a position in Bio-Techne in Q3 2020 and held it in 1 quarter.
  • Fortis Capital Management's Bio-Techne position peaked at $1.88M in Q3 2020.
  • 440 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2020.

Based on Fortis Capital Management's 13F filing for Q4 2020, filed 8 Feb 2021.